Crescent Capital BDC, Inc.
NASDAQ:CCAPAsset Management
-$0.06 today
- Market cap
- $365.51M
- Beta
- 0.57
- P/E (TTM)
- 27.5
- EPS (TTM)
- $0.41
- Dividend yield
- 11.93%
Volume 0.25M
Average 0.23M
CCAP EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Crescent Capital BDC, Inc.NASDAQ: CCAP
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA turns negative
Q1 FY2026 EBITDA was -$1.22M, compared with $4.41M a year earlier. Trailing-twelve-month EBITDA was $51.02M. Over 3 fiscal years it compounded at +84.2% a year.
Context
- EBITDA amounted to 66.0% of revenue in FY2025, up 13.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $73M (-29.2%) for the fiscal year ending Dec 2026, a slowdown from the +38.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.22M-104.1% QoQ
- Last fiscal yearDec 2025
- $103.11M+38.0% YoY
- LTMMar 2026
- $51.02M-1.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -127.7% | +15.6% | +143.3 pp |
| 1 year | +38.0% | -29.2% | -67.2 pp |
| 3-year CAGR | +84.2% | -12.6% | -96.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 103.11M USD
- Year-over-year change
- +38.0%
- 4-year CAGR
- +4.3%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 103.11M | +38.0% |
| FY2024 | 2024-12-31 | 74.74M | -11.1% |
| FY2023 | 2023-12-31 | 84.11M | +409.6% |
| FY2022 | 2022-12-31 | 16.51M | -81.1% |
| FY2021 | 2021-12-31 | 87.28M | — |
EBITDA vs competitors
How CCAP compares with its peers on the latest reported figures
- CCAP's LTM Mar 2026 EBITDA of $51.02M is the 4th highest of the 10 companies compared; the peer median is $27.21M.
- Its year-over-year change of -1.4% is the 6th highest of 10, against a peer median of +41.9%.
- EBITDA amounts to 40.9% of revenue for CCAP, versus a peer median of 71.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $133.05M | +101.8% | +67.8% | 118.5% | |
MSIFMSC Income Fund, Inc. | LTM Mar 2026 | $107.86M | +171.5% | — | 83.9% |
| LTM Mar 2026 | $79.24M | +58.4% | — | 96.3% | |
| LTM Mar 2026 | $51.02M | -1.4% | +84.2% | 40.9% | |
| LTM Mar 2026 | $50.46M | -43.5% | +48.9% | 71.5% | |
| LTM Mar 2026 | $27.21M | +303.8% | +7.7% | 18.4% | |
| LTM Jun 2025 | $19.88M | -44.6% | +22.3% | 48.4% | |
| LTM Mar 2026 | -$84.04M | +41.9% | — | 30.8% | |
| LTM Dec 2025 | -$85.17M | -57989.8% | — | 50.8% | |
| LTM Mar 2026 | -$94.98M | -103.0% | — | 388.5% | |
| Peer median (excluding CCAP) | $27.21M | +41.9% | +35.6% | 71.5% | |
Competitors are the stored peer set for CCAP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 101.1M | 52.1M | 147.33M | 142.44M | 156.19M |
| Cost of Revenue | 16.17M | 28.93M | 54.88M | 58.93M | 34.33M |
| Gross Profit | 84.93M | 23.17M | 92.46M | 83.5M | 121.85M |
| Gross Margin | 84.0% | 44.5% | 62.8% | 58.6% | 78.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 4.87M | 4.49M | 4.95M | 5.21M | 6.27B |
| Operating Expenses | (2.35M) | 6.67M | 8.35M | 8.76M | 2.92M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 9.48M |
| EBITDA | 87.28M | 16.51M | 84.11M | 74.74M | 103.11M |
| EBITDA Margin | 86.3% | 31.7% | 57.1% | 52.5% | 66.0% |
| Operating Income | 87.28M | 16.51M | 84.11M | 74.74M | 118.93M |
| Operating Margin | 86.3% | 31.7% | 57.1% | 52.5% | 76.1% |
| Interest Income | 85.66M | 108.52M | 169.87M | 182.94M | 142.94B |
| Interest Expense | 16.17M | 28.93M | 54.88M | 58.93M | 57.44M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (82.74M) |
| Income Before Tax | 87.28M | 16.51M | 84.11M | 74.74M | 36.19M |
| Pre-Tax Margin | 86.3% | 31.7% | 57.1% | 52.5% | 23.2% |
| Income Tax Expense | 3.65M | 961K | 274K | 1.09M | 1.68M |
| Net Income | 83.63M | 15.54M | 83.84M | 73.65M | 34.51M |
| Net Margin | 82.7% | 29.8% | 56.9% | 51.7% | 22.1% |
| EPS (Basic) | 2.94 | 0.50 | 2.33 | 1.99 | 0.93 |
| EPS (Diluted) | 2.94 | 0.50 | 2.33 | 1.99 | 0.93 |
| Weighted Avg Shares | 28.48M | 30.89M | 35.93M | 37.06M | 37.04M |
| Weighted Avg Shares (Diluted) | 28.48M | 30.89M | 35.93M | 37.06M | 37.04M |
Crescent Capital BDC, Inc.
NASDAQ:CCAP
Intrinsic Alpha fair value
Locked
Current Price
$9.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.